FDA Launches 'TEMPO' Pilot Program to Revitalize Digital Therapeutics Market
New regulatory model aims to overcome limitations of existing FDA approval process
The Light and Shadow of Digital Therapeutics
Digital therapeutics are software-based medical devices prescribed to treat specific diseases or disorders, regulated by the FDA. As of December 2024, the FDA has cleared 192 DTx devices, but the industry&
